{"id":"feclobuzone","rwe":[],"tags":[{"label":"feclobuzone","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":["feclobuzone"],"offLabel":[],"synonyms":["feclobuzone"],"timeline":[],"approvals":[],"ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"feclobuzone","explanation":"Unfortunately, there is no clear explanation of how FECLOBUZONE works, as its target and mechanism of action have not been fully elucidated. This lack of information makes it difficult to understand how the drug might interact with the body or produce its effects. More research is needed to shed light on its pharmacological properties.","oneSentence":"FECLOBUZONE is a small molecule that works by interacting with a specific biological target, but its exact mechanism of action is unknown.","technicalDetail":"FECLOBUZONE is a small molecule that binds to a specific protein or receptor, but the exact nature of this interaction and its downstream effects are unknown."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/1138","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=FECLOBUZONE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T11:13:47.904269","biosimilars":[],"competitors":[],"genericName":"feclobuzone","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"R6889JIL5D","INN_ID":"3187","RXNORM":"2391141","UMLSCUI":"C1880740","ChEMBL_ID":"CHEMBL2104250","PUBCHEM_CID":"176165"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","brandName":"FECLOBUZONE","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"FECLOBUZONE is a small molecule drug of the feclobuzone class, but details about its development, approval status, and commercial availability are limited. Its target and mechanism of action are unknown. As a result, there is no information available on its approved indications, half-life, bioavailability, or generic manufacturers. Further research is needed to understand the pharmacological properties and clinical applications of FECLOBUZONE. Its commercial status and safety considerations are also unclear.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}